Cormedix Stock Market Value
| CRMD Stock | USD 12.37 0.73 6.27% |
| Symbol | CorMedix |
CorMedix Price To Book Ratio
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CorMedix. If investors know CorMedix will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CorMedix listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 0.25 | Revenue Per Share | Quarterly Revenue Growth (0.47) | Return On Assets | Return On Equity |
The market value of CorMedix is measured differently than its book value, which is the value of CorMedix that is recorded on the company's balance sheet. Investors also form their own opinion of CorMedix's value that differs from its market value or its book value, called intrinsic value, which is CorMedix's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CorMedix's market value can be influenced by many factors that don't directly affect CorMedix's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CorMedix's value and its price as these two are different measures arrived at by different means. Investors typically determine if CorMedix is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CorMedix's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
CorMedix 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to CorMedix's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of CorMedix.
| 05/07/2025 |
| 08/05/2025 |
If you would invest 0.00 in CorMedix on May 7, 2025 and sell it all today you would earn a total of 0.00 from holding CorMedix or generate 0.0% return on investment in CorMedix over 90 days. CorMedix is related to or competes with Verrica Pharmaceuticals, Alaunos Therapeutics, Fennec Pharmaceuticals, Larimar Therapeutics, VTv Therapeutics, Oragenics, and Talphera. CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the preve... More
CorMedix Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure CorMedix's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess CorMedix upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 3.71 | |||
| Information Ratio | 0.0736 | |||
| Maximum Drawdown | 40.03 | |||
| Value At Risk | (4.30) | |||
| Potential Upside | 6.07 |
CorMedix Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for CorMedix's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as CorMedix's standard deviation. In reality, there are many statistical measures that can use CorMedix historical prices to predict the future CorMedix's volatility.| Risk Adjusted Performance | 0.0836 | |||
| Jensen Alpha | 0.4423 | |||
| Total Risk Alpha | (0.20) | |||
| Sortino Ratio | 0.1034 | |||
| Treynor Ratio | 1.14 |
CorMedix Backtested Returns
At this point, CorMedix is somewhat reliable. CorMedix secures Sharpe Ratio (or Efficiency) of 0.0425, which signifies that the company had a 0.0425 % return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for CorMedix, which you can use to evaluate the volatility of the firm. Please confirm CorMedix's Downside Deviation of 3.71, mean deviation of 3.09, and Risk Adjusted Performance of 0.0836 to double-check if the risk estimate we provide is consistent with the expected return of 0.19%. CorMedix has a performance score of 3 on a scale of 0 to 100. The firm shows a Beta (market volatility) of 0.43, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, CorMedix's returns are expected to increase less than the market. However, during the bear market, the loss of holding CorMedix is expected to be smaller as well. CorMedix right now shows a risk of 4.46%. Please confirm CorMedix semi variance, rate of daily change, and the relationship between the value at risk and kurtosis , to decide if CorMedix will be following its price patterns.
Auto-correlation | -0.37 |
Poor reverse predictability
CorMedix has poor reverse predictability. Overlapping area represents the amount of predictability between CorMedix time series from 7th of May 2025 to 21st of June 2025 and 21st of June 2025 to 5th of August 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of CorMedix price movement. The serial correlation of -0.37 indicates that just about 37.0% of current CorMedix price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.37 | |
| Spearman Rank Test | -0.3 | |
| Residual Average | 0.0 | |
| Price Variance | 2.06 |
CorMedix lagged returns against current returns
Autocorrelation, which is CorMedix stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting CorMedix's stock expected returns. We can calculate the autocorrelation of CorMedix returns to help us make a trade decision. For example, suppose you find that CorMedix has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
CorMedix regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If CorMedix stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if CorMedix stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in CorMedix stock over time.
Current vs Lagged Prices |
| Timeline |
CorMedix Lagged Returns
When evaluating CorMedix's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of CorMedix stock have on its future price. CorMedix autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, CorMedix autocorrelation shows the relationship between CorMedix stock current value and its past values and can show if there is a momentum factor associated with investing in CorMedix.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether CorMedix is a strong investment it is important to analyze CorMedix's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact CorMedix's future performance. For an informed investment choice regarding CorMedix Stock, refer to the following important reports:Check out CorMedix Correlation, CorMedix Volatility and CorMedix Alpha and Beta module to complement your research on CorMedix. For information on how to trade CorMedix Stock refer to our How to Trade CorMedix Stock guide.You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
CorMedix technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.